Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today announced its
BioLineRx Ltd (NASDAQ:BLRX) announced results from the Phase 1/2a study of the intratumoral cancer vaccine candidate AGI-134 in patients with unresectable…
Analyst at Piper Sandler cut their revenue and iPhone sales estimates for Apple Inc’s (NASDAQ:AAPL) December quarter, as Beijing’s strict lockdowns hamper…